drugset
drugset / Trial / NCT03590873

The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients

NCT03590873 ↗

Unknown 158 enrolled Hangang Sacred Heart Hospital Asan Medical Center · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the restrictive group to further evaluate significant differences in intraoperative blood loos during burn surgery.

Timeline

Start
2018-07-25
Primary completion
2019-06-04
Completion
2019-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide — —

Indications

No indication recorded.